| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |